2011年至2020年中国门的鼻癌:基于人口的联系研究
Jiali Quan1,2, Aiping Zhou3,4, Zhinan Guo1
1Xiamen Center for Disease Control and Prevention, Xiamen, Fujian, China.
BMC cancer
|December 7, 2025
概括
鼻癌 (NPC) 发病率在门从2011年到2020年显著下降. 虽然死亡率显著下降,但生存率有所改善,这表明需要加强预防和治疗策略.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 鼻癌 (NPC) 在全球很少见,但在中国南部非常普遍.
- 这项研究侧重于门的NPC趋势,这是一个发病率高的地区.
研究的目的:
- 分析2011年至2020年门NPC的发病率,死亡率,生命损失年数 (YLL) 和生存率.
- 确定趋势并为未来的公共卫生干预提供数据.
主要方法:
- 利用来自门市癌症登记处和癌症随访队列 (2011-2020) 的数据.
- 分析了原始和年龄标准化率 (发病率,死亡率,年均死亡率,存活率),使用年度百分比变化 (APC) 和平均年度百分比变化 (AAPC).
- 按性别和居住状态进行分层分析.
主要成果:
- 在2011-2020年期间,NPC病例996例,死亡513例.
- 年龄标准化发病率显示显著下降 (AAPC: -5.48%).
- 五年标准化的相对存活率为55.98%.
结论:
- 在过去的十年里,NPC发病率在门持续下降.
- 死亡率趋势呈现微不足道的下降,突出显示需要继续努力.
- 建议加强预防,查和治疗策略,以加强积极的趋势.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


